Approval · Notice of Compliance 31017 · 2023
ATIPAM: Notice of Compliance 31017
Issued June 21, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31017
- Date
- June 21, 2023
- Company
- Eurovet Animal Health B V
- Product type
- Veterinary
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Manufacturing changes for drug product
- Canadian reference product
- ANTISEDAN (Orion Corporation)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ATIPAM | Not yet assigned | — |
Medicinal ingredients
- ATIPAMEZOLE HYDROCHLORIDE 5 MG per ML